期刊文献+

2013—2015年我国丙型病毒性肝炎病例报告数据质量核查分析 被引量:29

Reporting quality of hepatitis C cases in China, 2013-2015
原文传递
导出
摘要 目的了解医疗机构丙型病毒性肝炎(丙肝)病例报告存在的问题,提高数据质量。方法 2013—2015年,选择丙肝病例报告数较多的县(区)及以上级别的医院,对其当年1季度丙肝相关病例数据质量进行核查。结果 2013—2015年丙肝病毒抗体阳性报告率分别为44.3%、55.5%和58.3%,核酸阳性报告率分别为46.8%、52.1%和65.6%;诊断分类正确率分别为25.4%、44.6%和44.0%,急慢性分类正确率分别19.2%、38.1%和53.9%。丙肝病例报告率和分类正确率均处于较低水平,但逐年提高。结论目前我国医疗机构丙肝病例报告质量普遍存在报告率低和分类正确率低的问题,建议完善修订现行《丙肝诊断标准》、加强培训和督导,提高工作质量。 Objective To understand the problems existing in cases reporting of hepatitis C in medical facilities in China, and provide evidence to improve the quality of data. Methods The medical facilities at or above the county level which reported more hepatitis C cases from 2013 to 2015 were selected, and the data quality of related cases during the first quarter of a year were checked. Results From 2013 to 2015 ,the reporting rates of anti-HCV positive cases were 44. 3%, 55.5% and 58.3%, respectively. The reporting rates of HCV-RNA positive cases were 46. 8%, 52. 1% and 65. 6%, respectively. The rates of correct diagnosis was 25.4%, 44. 6% and 44.0%, respectively. The rates of correct acute or chronic classification were 19.2%, 38.1% and 53.9%, respectively. Both the reporting rates and correct classification rate of hepatitis C were low but increased year by year. Condasion Problems existed in the reporting of hepatitis C cases in China. It is suggested to improve and revise hepatitis C diagnosed criteria and strengthen medical staff training in order to improve the quality of hepatitis C case reporting.
出处 《疾病监测》 CAS 2017年第6期513-515,共3页 Disease Surveillance
关键词 丙型病毒性肝炎 病例报告 数据质量 Hepatitis C Case reporting Data quality
  • 相关文献

参考文献1

二级参考文献5

  • 1Koike K, Tsukada K, otsuyanagi K. Preva lence of coinfection with hu- man immunodeficiency virus and hepatitis C virus in Japan [ J ]. Hepatol Res ,2007,37 ( 1 ) :2 - 5.
  • 2Sulkowski MS, Moore RD, Mehta SH, et al. Hepatitis C and progressionof HIV disease [ J ]. JAMA, 2002,28 ( 8 ) : 199 - 206.
  • 3Carrat F, Bani-Sadr F, Pol S, et al. Pegylated interferon alfa-2b vs stand- ard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-in- fected patients: a randomized controlled trial[ J]. JAMA,2004,29(2) : 2839 - 2848.
  • 4Laguno M, Murillas J, Blanco JL, et al. Peginterferon alfa-2b plus ribavi- rin compared with interferon alfa-2b plus ribavirin for treatment of HIV/ HCV co-infected patients [ J ]. AIDS ,2004,18 (6) :F27 -F36.
  • 5阴宁,梅珊,李莉,魏飞力,张林琦,曹韵贞.中国经血传播人群中艾滋病病毒-1与丙型肝炎病毒亚型分布研究[J].中华流行病学杂志,2003,24(11):962-965. 被引量:30

共引文献6

同被引文献200

引证文献29

二级引证文献104

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部